NOVAST Passes On-site GMP Inspection by Jiangsu Medical Products Administration

On October 18, 2021, Jiangsu Medical Products Administration (JSMPA) released the announcement (No. 2021-81):

In accordance with the relevant provisions of the Drug Administration Law and the Measures for the Supervision and Administration of Drug Production, after on-site inspection and comprehensive assessment, the results are announced that NOVAST complies with the requirements of Good Manufacturing Practices (GMP) .